NOTCH3 and pulmonary arterial hypertension: Increased expression of Notch3 signalling pathway components has been demonstrated in pulmonary VSMCs from patients with PAH and the severity of PAH correlated with the amount of Notch3 protein in the lung in humans and rodents [11].